Patients with a History of Bariatric Surgery Are 8 Years Younger at Presentation with Severe Alcoholic Hepatitis

• Published in: Obesity surgery 2023, Vol.33 (1), p.284-292
• Main Authors: Van Melkebeke, Lukas, Broekhoven, Annelotte G. C., Ostyn, Tessa, Korf, Hannelie, Coenraad, Minneke J., Vangoitsenhoven, Roman, Van der Schueren, Bart, Lannoo, Matthias, Van Malenstein, Hannah, Roskams, Tania, van der Merwe, Schalk, Nevens, Frederik, Verbeek, Jef
• Format: Article
• Language: English
• Subjects: Bariatric Surgery - adverse effects; Biopsy; Female; Gastrectomy - adverse effects; Gastric Bypass - adverse effects; Gastrointestinal surgery; Hepatitis; Hepatitis, Alcoholic - complications; Hepatitis, Alcoholic - surgery; Humans; Medicine; Medicine & Public Health; Obesity, Morbid - surgery; Original Contributions; Retrospective Studies; Surgery; Treatment Outcome
• ISSN: 0960-8923; 1708-0428
• DOI: 10.1007/s11695-022-06386-1

Purpose Patients with prior bariatric surgery (BS) are at risk to develop alcohol use disorder (AUD) and alcohol-related liver disease (ALD). Severe alcoholic hepatitis (sAH) is one of the most severe manifestations of ALD with a 28-day mortality of 20–50%. The impact of prior BS on patients presenting with sAH was assessed. Methods From 01/2008 to 04/2021, consecutive patients admitted to a tertiary referral center with biopsy-proven sAH were included in a database. Results One hundred fifty-eight sAH patients of which 28 patients had a history of BS (BS group) were identified. Of this BS group, 24 patients underwent a Roux-en-Y gastric bypass (RYGB), 3 a biliopancreatic diversion, 1 an adjustable gastric band, and no patients a sleeve gastrectomy. The proportion of patients with BS increased threefold over time during the study period. Patients in the BS group were significantly younger at diagnosis of sAH (44.3 years vs 52.4 years), were more frequently female, and had a higher body mass index and a higher grade of steatosis on liver biopsy. The correlation between BS and a younger age at diagnosis remained significant in a multivariate regression analysis. There were no differences in disease severity between both groups. Furthermore, there were no differences in corticosteroid response, 28-day, 90-day, or 1-year survival. Conclusion Prior BS is independently associated with a younger age of presentation with sAH, but is not independently associated with a different disease severity or outcome. These findings support the need for early detection of AUD in patients who underwent BS, in particular RYGB.